Valion Bio, Inc.
VBIO
$2.44
-$0.06-2.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.75M | -13.58M | -8.88M | -7.51M | -6.34M |
| Total Depreciation and Amortization | 793.00K | 185.00K | 5.00K | 275.00K | 276.00K |
| Total Amortization of Deferred Charges | 934.00K | 445.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.68M | 1.55M | 1.33M | 1.53M | 1.03M |
| Change in Net Operating Assets | 675.00K | 183.00K | 452.00K | -377.00K | -450.00K |
| Cash from Operations | -14.58M | -11.12M | -7.00M | -6.08M | -5.49M |
| Capital Expenditure | -99.00K | -45.00K | -38.00K | -13.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.00K | -141.00K | -667.00K | -543.00K | -543.00K |
| Cash from Investing | -223.00K | -186.00K | -705.00K | -556.00K | -546.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 498.00K | 2.34M | 2.45M | 3.56M | 3.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 15.87M | 16.21M | 16.21M | 4.34M | 585.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -273.00K | -325.00K | -308.00K | -5.00K | -207.00K |
| Cash from Financing | 16.09M | 18.22M | 18.35M | 7.89M | 3.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.29M | 6.91M | 10.64M | 1.26M | -2.51M |